Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 790.34M P/E 259.00 EPS this Y 69.20% Ern Qtrly Grth 26.10%
Income 5.72M Forward P/E 37.00 EPS next Y 36.40% 50D Avg Chg 5.00%
Sales 174.54M PEG 0.48 EPS past 5Y - 200D Avg Chg -1.00%
Dividend N/A Price/Book 12.05 EPS next 5Y 85.70% 52W High Chg -38.00%
Recommedations 2.70 Quick Ratio 3.14 Shares Outstanding 89.87M 52W Low Chg 41.00%
Insider Own 8.53% ROA 6.42% Shares Float 39.60M Beta 1.01
Inst Own 95.87% ROE 10.23% Shares Shorted/Prior 2.17M/3.02M Price 10.36
Gross Margin 66.98% Profit Margin 3.45% Avg. Volume 455,491 Target Price 9.96
Oper. Margin 4.59% Earnings Date May 9 Volume 304,539 Change -2.91%
About Enfusion, Inc.

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Enfusion, Inc. News
04/18/24 Enfusion Announces Date of First Quarter 2024 Results
04/04/24 The 3 Most Undervalued Under-$10 Stocks to Buy in April 2024
04/02/24 Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?
03/21/24 Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
03/15/24 Wall Street Favorites: 3 Under-$10 Stocks with Strong Buy Ratings for March 2024
03/14/24 Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcript
03/12/24 Q4 2023 Enfusion Inc Earnings Call
03/12/24 Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
03/12/24 Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
03/12/24 Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
03/05/24 Box (BOX) Q4 Earnings Beat Estimates
03/05/24 Strength Seen in Phunware (PHUN): Can Its 75.3% Jump Turn into More Strength?
02/27/24 A Look At The Fair Value Of Enfusion, Inc. (NYSE:ENFN)
02/13/24 Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results
02/12/24 Enfusion to Host Investor Day on March 19, 2024
01/30/24 Kore.ai Secures $150 Million Strategic Growth Investment to Drive AI-powered Customer and Employee Experiences for Global Brands
01/24/24 BillingPlatform Secures $90 Million Growth Equity Investment from FTV Capital
01/18/24 Enfusion Elevates Valeria Gutowski to Chief Accounting Officer
01/17/24 Here's What's Concerning About Enfusion's (NYSE:ENFN) Returns On Capital
12/18/23 What You Can Learn From Enfusion, Inc.'s (NYSE:ENFN) P/S
ENFN Chatroom

User Image Stock_Titan Posted - 1 week ago

$ENFN Enfusion Announces Date of First Quarter 2024 Results https://www.stocktitan.net/news/ENFN/enfusion-announces-date-of-first-quarter-2024-kkjvaaouvuqa.html

User Image KCclean Posted - 2 weeks ago

$ENFN I chased anyway.

User Image Zit1343 Posted - 1 month ago

$ENFN right on the money 💰 Follow me for more Alerts 🚨 & Gain 💰💵💲 Lmk if you want to be study this stock again

User Image Stock_Titan Posted - 1 month ago

$ENFN $GLOB ParkHub and JustPark Agree to Merge Alongside Strategic Growth Investment from FTV Capital and LLR Partners https://www.stocktitan.net/news/ENFN/park-hub-and-just-park-agree-to-merge-alongside-strategic-growth-qmp3txrp2qs7.html

User Image Stock_Titan Posted - 1 month ago

$ENFN Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion https://www.stocktitan.net/news/ENFN/kayne-anderson-strengthens-investment-operations-after-successful-53qutpcu8074.html

User Image DonCorleone77 Posted - 1 month ago

$ENFN Enfusion to hold an analyst and investor day Analyst and Investor Day to be held in Fort Lauderdale on March 19 at 8:30 am.

User Image DonCorleone77 Posted - 1 month ago

$ENFN Enfusion to hold an analyst and investor day Analyst and Investor Day to be held in Fort Lauderdale on March 19 at 8:30 am.

User Image KCclean Posted - 1 month ago

$ENFN Interested @ $8 or $10

User Image DonCorleone77 Posted - 1 month ago

$ENFN Enfusion sees FY24 revenue $200M-$210M, consensus $202.3M Sees FY24 adjusted EBITDA $40M-$45M. Sees FY24 free cash flow conversion 50%-55%.

User Image DonCorleone77 Posted - 1 month ago

$ENFN Enfusion reports Q4 adjusted EPS 4c, consensus 5c Reports Q4 revenue $46.49M, consensus $45.27M. The company said, "I'm pleased to share that Enfusion ended 2023 with excellent financial performance and increased momentum as we start 2024. Our results demonstrate our ability to navigate a challenging macroeconomic backdrop while exceeding our expectations for operating margin improvement and customer wins. We continue to focus on our primary mission of powering all investment workflows with unparalleled technology, relentless innovation, and dedicated focus on our clients."

User Image Stock_Titan Posted - 1 month ago

$ENFN Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results https://www.stocktitan.net/news/ENFN/enfusion-announces-fourth-quarter-2023-results-and-full-year-2023-4md3yh68xzsb.html

User Image EatingCatPoop Posted - 1 month ago

$ENFN dump eet

User Image insiderbuyingselling Posted - 1 month ago

$ENFN new insider selling: 108 shares. http://insiderbuyingselling.com/?t=ENFN

User Image briefingcom Posted - 02/28/24

$ENFN (-4.6%) downgraded to Sell from Neutral at Goldman; tgt $8 https://www.briefing.com/calendars/updown?Filter=Downgrades

User Image erevnon Posted - 02/28/24

Goldman Sachs downgrades Enfusion $ENFN from Neutral to Sell and cuts the price target from $9 to https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Zit1343 Posted - 2 months ago

$ENFN can go up to $9.50 or higher…

User Image Stock_Titan Posted - 2 months ago

$ENFN Enfusion Announces Date of Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/ENFN/enfusion-announces-date-of-fourth-quarter-and-full-year-2023-ygznhqp174n3.html

User Image Zit1343 Posted - 2 months ago

$ENFN bullish. It is falling back in range.

User Image TickerDD_com Posted - 2 months ago

From 2/6/2024, looking back across 22 Month-Ends for ENFN, Percentage Change of Average Monthly Price had More Negatives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ENFN #ENFN #ENFNStock #TickerDD #ENFNPrice https://www.youtube.com/watch?v=qKXSJbKCI5k

User Image Stock_Titan Posted - 2 months ago

$ENFN Enfusion to Host Investor Day on March 19, 2024 https://www.stocktitan.net/news/ENFN/enfusion-to-host-investor-day-on-march-19-tc3wt9jx6ajc.html

User Image BigBreakingWire Posted - 01/30/24

🚨Enfusion shares decline by 7.4% following JP Morgan's downgrade of the stock from Neutral to Underweight, coupled with a reduction in its price target from $11 to $9. Live update https://bigbreakingwire.in/stock-in-news $ENFN $JPM

User Image Thestocktraderhubzee Posted - 01/30/24

$ENFN Enfusion shares are trading lower after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $11 to $9.

User Image briefingcom Posted - 01/30/24

$ENFN (-3.5%) downgraded to Underweight from Neutral at JP Morgan; tgt $9 https://www.briefing.com/calendars/updown?Filter=Downgrades

User Image cctranscripts Posted - 3 months ago

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12888263 $ENFN

User Image cctranscripts Posted - 3 months ago

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12884573 $ENFN

User Image cctranscripts Posted - 3 months ago

Enfusion, Inc.'s Chief Accounting Officer just declared owning 17,597 shares of Enfusion, Inc. https://www.conferencecalltranscripts.org/summary/?id=12880999 $ENFN

User Image cctranscripts Posted - 3 months ago

Stephen Malherbe just provided an update on share ownership of Enfusion, Inc. https://www.conferencecalltranscripts.org/summary/?id=12880448 $ENFN

User Image Last10K Posted - 3 months ago

$ENFN just filed with the SEC a Event for Officers, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/ENFN/0001558370-24-000349.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ENFN

User Image cctranscripts Posted - 3 months ago

Enfusion Elevates Valeria Gutowski To Chief Accounting Officer January 18, 2024 https://www.conferencecalltranscripts.org/summary/?id=12875380 $ENFN

User Image risenhoover Posted - 3 months ago

$ENFN / Enfusion files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2024 Enfusion, Inc. ( https://fintel.io/doc/sec-enfusion-inc-1868912-8k-2024-january-18-19740-2182?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
B of A Securities Underperform Mar 13, 24
Goldman Sachs Sell Feb 28, 24
JP Morgan Underweight Jan 30, 24
Piper Sandler Neutral Dec 20, 23
UBS Neutral Nov 7, 23
Goldman Sachs Neutral Aug 9, 23
Morgan Stanley Overweight Aug 9, 23
Piper Sandler Neutral May 22, 23
Credit Suisse Neutral May 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Somers Deirdre Director Director Jan 10 Sell 8.65 1,770 15,310 34,471 01/12/24
Movchan Oleg Chief Executive Offi.. Chief Executive Officer Jan 08 Sell 9.09 2,650 24,088 269,954 01/10/24
Campobasso Matthew General Counsel General Counsel Jan 08 Sell 9.09 965 8,772 30,948 01/10/24
Herring Bradley Chief Financial Offi.. Chief Financial Officer Jan 08 Sell 9.09 4,088 37,160 211,600 01/10/24
Bastone Bronwen Chief People Officer Chief People Officer Jan 08 Sell 9.09 801 7,281 153,846 01/10/24
Movchan Oleg Chief Executive Offi.. Chief Executive Officer Dec 14 Sell 10.01 100,000 1,001,000 1,151,818 12/18/23
Movchan Oleg Chief Executive Offi.. Chief Executive Officer Dec 01 Sell 10.09 150,000 1,513,500 1,251,818 12/05/23
Malherbe Stephen 10% Owner 10% Owner Nov 27 Sell 9.86 1,000,000 9,860,000 11/28/23
Groman Dan Chief Technology Off.. Chief Technology Officer Nov 14 Sell 9.97 5,000 49,850 133,828 11/16/23
Bastone Bronwen Chief People Officer Chief People Officer Aug 11 Sell 7.89 41 323 156,855 08/15/23
Groman Dan Chief Technology Off.. Chief Technology Officer Aug 11 Sell 7.89 1,760 13,886 119,418 08/15/23
Bastone Bronwen Chief People Officer Chief People Officer Aug 10 Sell 8.1 44 356 156,779 08/14/23
Groman Dan Chief Technology Off.. Chief Technology Officer Aug 10 Sell 8.1 1,850 14,985 117,133 08/14/23
Bastone Bronwen Chief People Officer Chief People Officer Aug 09 Sell 8.08 50 404 156,693 08/11/23
Groman Dan Chief Technology Off.. Chief Technology Officer Aug 08 Sell 8.32 2,317 19,277 111,783 08/10/23
Bastone Bronwen Chief People Officer Chief People Officer Aug 08 Sell 8.32 55 458 156,602 08/10/23
Hammoud Tarek 10% Owner 10% Owner Jul 11 Sell 10.70 1,000,000 10,700,000 386 07/13/23
Bernstein Bradford E Director Director Oct 25 Sell 15.895 4,075,531 64,780,565 31,297,606 04/21/22
Luo Roy Director Director Oct 25 Buy 17 1,261,594 21,447,098 722,707 10/27/21
ICONIQ Strategic Partners V, L... 10% Owner 10% Owner Oct 25 Buy 17 1,261,594 21,447,098 722,707 10/27/21